GB Patent

GB8630913D0 — Pharmaceutical compositions

Assigned to Glaxo Group Ltd · Expires 1987-02-04 · 39y expired

What this patent protects

Use of fluticasone propionate in the treatment of bowel diseases when administered by the oral, stomal or rectal routes.

USPTO Abstract

Use of fluticasone propionate in the treatment of bowel diseases when administered by the oral, stomal or rectal routes.

Drugs covered by this patent

Patent Metadata

Patent number
GB8630913D0
Jurisdiction
GB
Classification
—
Expires
1987-02-04
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.